China Pharma Holdings (CPHI) Enterprise Value (2010 - 2026)
China Pharma Holdings (CPHI) posted Enterprise Value of -$168474.0 for Q1 2026, up 51.18% on a QoQ basis from -$345112.0 in Q4 2025, and up 59.18% year-over-year from -$105841.1 in Q1 2025.
China Pharma Holdings (CPHI) Enterprise Value (2010 - 2026) Analysis & Trends
China Pharma Holdings' Enterprise Value history runs 17 years deep, the most recent figure standing at -$168474.0 for Q1 2026.
- Quarterly Enterprise Value rose 59.18% year-over-year to -$168474.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$168474.0 (up 59.18% YoY) and the FY2025 annual result came in at -$345112.0, up 44.95% from the prior year.
- Enterprise Value was -$168474.0 for Q1 2026 at China Pharma Holdings, up from -$345112.0 in the prior quarter.
- Across five years, Enterprise Value topped out at -$168474.0 in Q1 2026 and bottomed at -$3.7 million in Q1 2022.
- A 5-year average of -$1.2 million and a median of -$838881.0 in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value tumbled 594.97% — and 2023, when it surged 68.59%.
- China Pharma Holdings' Enterprise Value stood at -$2.0 million in 2022, then gained by 29.86% to -$1.4 million in 2023, then surged by 55.97% to -$626879.0 in 2024, then jumped by 44.95% to -$345112.0 in 2025, then jumped by 51.18% to -$168474.0 in 2026.
- Business Quant data shows CPHI's Enterprise Value at -$168474.0 in Q1 2026, -$345112.0 in Q4 2025, and -$267625.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | -168,474.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -168,474.00 |
| Dec 31, 2025 | -345,112.00 |
| Sep 30, 2025 | -267,625.00 |
| Jun 30, 2025 | -625,032.00 |
| Mar 31, 2025 | -412,688.00 |
| Dec 31, 2024 | -626,879.00 |
| Sep 30, 2024 | -718,691.00 |
| Jun 30, 2024 | -739,337.00 |
| Mar 31, 2024 | -838,881.00 |
| Dec 31, 2023 | -1.42 Mn |
| Sep 30, 2023 | -1.37 Mn |
| Jun 30, 2023 | -901,910.00 |
| Mar 31, 2023 | -1.17 Mn |
| Dec 31, 2022 | -2.03 Mn |
| Sep 30, 2022 | -2.10 Mn |
| Jun 30, 2022 | -2.20 Mn |
| Mar 31, 2022 | -3.71 Mn |
| Dec 31, 2021 | -4.86 Mn |
| Sep 30, 2021 | -500,000.00 |
| Jun 30, 2021 | -1.80 Mn |